Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in national pharmaceutical pricing authority

COVID-19: NPPA caps price of Liquid Medical Oxygen and Medical Oxygen cylinders

COVID-19: NPPA caps price of Liquid Medical Oxygen and Medical Oxygen cylinders

Read More

NPPA monitoring price of critical medical equipment for COVID-19

NPPA monitoring price of critical medical equipment for COVID-19

Read More

Rationalise Govt Intervention To Boost Economic Freedom, Wealth Creation

The Survey suggests that "the Act must be jettisoned in order to grant more economic freedom to the market and to facilitate the process of wealth creation in the economy."

Read More

Fortis Dengue Case: NPPA Seeks Bill Copies From Hospital

Haryana government has set up a three-member committee to probe allegations that Gurugram's Fortis Hospital overcharged the family of the 7-year-old girl, who died of dengue

Read More

Reforming India’s Healthcare System

The problems in government hospitals are of a different dimension entirely... sanitary conditions and infrastructure

Read More

No Price Change In 78% Of Actively Used Drugs Post GST: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

Read More

Prices Of Many Essential Drugs To Rise Up To 2.29% Post GST

The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.

Read More

Goverment Extends Price Control Over Commonly Used Vaccinations And Medicines

Drug price watchdog, National Pharmaceutical Pricing Authority (NPPA) has fixed or revised retail prices of 37 scheduled formulations

Read More

Dr Reddy's Sees No Impact From Pricing Regulator Notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.

Read More

Drugs For Cancer, Autism See Up To 86% Price Cut In A Year

Drug pricing regulator NPPA has slashed price of cancer drugs by up to 86 per cent since March last year providing relief to lakhs of patients

Read More

Affordability At Cost Of Innovation?

Stents and other cost issues in the context of affordability of healthcare in India assume importance as price control can also affect innovation

Read More